O'Shaughnessy Asset Management
DXCM icon

O'Shaughnessy Asset Management’s DexCom DXCM Stock Holding History

O'Shaughnessy Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.77M Buy
31,347
+7,377
+31% +$614K 0.01% 814
2026
Q2 		$1.61M Sell
23,970
-9,396
-28% -$626K 0.01% 1022
2026
Q1 		$2.1M Buy
33,366
+18,683
+127% +$1.3M 0.01% 858
2025
Q4 		$975K Sell
14,683
-5,026
-26% -$325K 0.01% 1161
2025
Q3 		$1.33M Buy
19,709
+391
+2% +$30.9K 0.01% 1003
2025
Q2 		$1.69M Buy
19,318
+1,677
+10% +$131K 0.01% 844
2025
Q1 		$1.2M Buy
17,641
+4,257
+32% +$347K 0.01% 916
2024
Q4 		$1.04M Buy
13,384
+1,930
+17% +$143K 0.01% 949
2024
Q3 		$792K Sell
11,454
-13,784
-55% -$1.13M 0.01% 1014
2024
Q2 		$2.86M Buy
25,238
+3,211
+15% +$406K 0.03% 501
2024
Q1 		$3.06M Buy
22,027
+4,481
+26% +$563K 0.03% 462
2023
Q4 		$2.18M Buy
17,546
+1,924
+12% +$197K 0.03% 510
2023
Q3 		$1.46M Buy
15,622
+2,371
+18% +$267K 0.02% 568
2023
Q2 		$1.7M Buy
13,251
+1,827
+16% +$221K 0.03% 495
2023
Q1 		$1.33M Sell
11,424
-745
-6% -$83.4K 0.02% 566
2022
Q4 		$1.38M Buy
12,169
+3,256
+37% +$357K 0.02% 516
2022
Q3 		$718K Buy
8,913
+2,522
+39% +$214K 0.01% 632
2022
Q2 		$476K Sell
6,391
-393
-6% -$35.9K 0.01% 703
2022
Q1 		$868K Buy
6,784
+1,248
+23% +$137K 0.01% 566
2021
Q4 		$743K Buy
5,536
+100
+2% +$14.4K 0.01% 587
2021
Q3 		$743K Buy
5,436
+1,608
+42% +$203K 0.02% 546
2021
Q2 		$409K Buy
3,828
+916
+31% +$88K 0.01% 740
2021
Q1 		$262K Buy
2,912
+64
+2% +$6.01K 0.01% 823
2020
Q4 		$263K Sell
2,848
-816
-22% -$72.9K 0.01% 733
2020
Q3 		$378K Sell
3,664
-600
-14% -$62.7K 0.01% 515
2020
Q2 		$432K Buy
4,264
+3,140
+279% +$281K 0.01% 433
2020
Q1 		$76K Buy
1,124
+1,008
+869% +$62.7K ﹤0.01% 694
2019
Q4 		$6K Buy
+116
New +$5.5K ﹤0.01% 1409

Other funds holding DXCM

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

O'Shaughnessy Asset Management's DXCM Position: Q3 2026 in Review

O'Shaughnessy Asset Management increased its DexCom (DXCM) stake by 31% in Q3 2026, buying an estimated $614K and bringing the position to 31,347 shares worth $2.77M. The position accounts for 0.01% of the portfolio, ranked #814.

O'Shaughnessy Asset Management first reported a position in DXCM in Q4 2019 and has held it in 28 quarters since. The position peaked at $3.06M in Q1 2024. 863 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • O'Shaughnessy Asset Management held 31,347 shares of DexCom worth $2.77M as of Q3 2026.
  • O'Shaughnessy Asset Management bought 7,377 DexCom shares in Q3 2026, an estimated $614K.
  • DexCom made up 0.01% of O'Shaughnessy Asset Management's portfolio in Q3 2026, its #814 holding.
  • O'Shaughnessy Asset Management first reported a position in DexCom in Q4 2019 and has held it in 28 quarters since.
  • O'Shaughnessy Asset Management's DexCom position peaked at $3.06M in Q1 2024.
  • 863 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.